View in web browser   |   Add to safe senders
MIMS
Prescribing Update 16th December 2017
Latest updates
 
New MIMS table helps GPs adjust antidiabetic doses in renal impairment New MIMS table helps GPs adjust antidiabetic doses in renal impairment
8 December 2017, 4:14pm
Prescribers can now consult a handy MIMS table to check the dose adjustments needed when prescribing diabetes medications in patients with kidney disease.
 
New once-daily triple combination inhaler for COPD New once-daily triple combination inhaler for COPD
14 December 2017, 11:18am
Trelegy Ellipta is the second 3-in-1 treatment for chronic obstructive pulmonary disease (COPD) to be launched in the UK, combining the inhaled corticosteroid fluticasone, the long-acting beta2-agonist vilanterol and the long-acting muscarinic antagonist umeclidinium.
 
New obesity treatment rejected by NICE New obesity treatment rejected by NICE
13 December 2017, 10:45am
The obesity treatment naltrexone/bupropion (Mysimba) should not be routinely prescribed on the NHS, NICE has decided.
 
New Products

Products added to MIMS.

 
Deleted Products

Products removed from MIMS.

 
 

 

 
Did you miss?
 
First NICE asthma guideline recommends oral treatment before LABA
 
Dupilumab: first biologic for moderate-to-severe atopic dermatitis
 

Featured MIMS resources

Smoking Cessation Treatments

At-a-glance comparison table of smoking cessation treatments.

 

Management of COPD


At-a-glance summary of NICE guidance for COPD treatment.

 
Manage Bulletins Unsubscribe